Navigen

Navigen

Pharmaceuticals, 383 S Colorow Dr Ste 106, Salt Lake City, Utah, 84108, United States, 11-50 Employees

navigenpharma.com

  • twitter
  • LinkedIn

phone no Phone Number: +18*********

Who is NAVIGEN

Navigen, Inc. is a Salt Lake City-based pharmaceutical discovery and development company. Our early strategy was to source early-stage technologies from academia and advance them to IND-e...

Read More

map
  • 383 S Colorow Dr Ste 106, Salt Lake City, Utah, 84108, United States Headquarters: 383 S Colorow Dr Ste 106, Salt Lake City, Utah, 84108, United States
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $1 Million to $5 Million

industries-icon Industry: Pharmaceuticals

SIC SIC Code: 8731 | NAICS Code: 541711 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from NAVIGEN

Navigen Org Chart and Mapping

Employees

Similar Companies to Navigen

Abalone Bio

  • 11-50 11-50
  • 1 Million to 5 Million $ 1 Million to 5 Million

Juvena Therapeutics

  • 11-50 11-50
  • 1 Million to 5 Million $ 1 Million to 5 Million

Merck

  • 10001+ 10001+
  • 1 Billion and Over $ 1 Billion and Over
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Navigen

Answer: Navigen's headquarters are located at 383 S Colorow Dr Ste 106, Salt Lake City, Utah, 84108, United States

Answer: Navigen's phone number is +18*********

Answer: Navigen's official website is https://navigenpharma.com

Answer: Navigen's revenue is $1 Million to $5 Million

Answer: Navigen's SIC: 8731

Answer: Navigen's NAICS: 541711

Answer: Navigen has 11-50 employees

Answer: Navigen is in Pharmaceuticals

Answer: Navigen top competitors include: Abalone Bio , Juvena Therapeutics , Merck

Answer: Navigen contact info: Phone number: +18********* Website: https://navigenpharma.com

Answer: Navigen, Inc. is a Salt Lake City-based pharmaceutical discovery and development company. Our early strategy was to source early-stage technologies from academia and advance them to IND-enabling studies using non-dilutive funding from grants, contracts, and corporate collaborations. We have been successfully executed on that strategy, having raised approximately $40 MM in non-dilutive funding and advancing two of our programs to pre-IND studies with the goal of filing IND applications on both within 12-14 months.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access